Construction of competing-risk nomograms and identification of optimal candidates for aggressive therapy in gastric cancer with peritoneal metastasis: a population-based study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: The optimal treatment strategies for gastric cancer with peritoneal metastasis (GCPM) are extensively debated, especially regarding the appropriateness of aggressive local treatments. This study aimed to construct robust competing-risk nomograms for prognostic prediction and to establish a novel risk-stratification system to facilitate individualized therapeutic decision-making. Methods: Patients diagnosed with GCPM between 2010 and 2015 were identified from the Surveillance, Epidemiology, and End Results (SEER) database and randomly divided into training and validation cohorts at a 7:3 ratio. Propensity score matching (PSM) was applied to evaluate the survival impact of different treatment strategies. Independent prognostic factors in the training cohort were selected using a combination of least absolute shrinkage and selection operator (LASSO) regression and stepwise Akaike information criterion (AIC), and these variables were subsequently used to construct Cox [for overall survival (OS)] and Fine-Gray [for cancer-specific survival (CSS)] nomograms. Model discrimination, calibration, predictive accuracy, and clinical utility were assessed using the concordance index (C-index), receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Risk stratification was further performed based on the nomogram-derived scores, and treatment benefits were analyzed across different risk groups. Results: A total of 4,280 patients were included, comprising 2,996 in the training cohort and 1,284 in the validation cohort. PSM analysis demonstrated that, among unstratified patients, aggressive therapy significantly improved survival compared with chemotherapy-based treatment (P
Fields of Study & Subjects
Intraperitoneal and Appendiceal Malignancies
Gastric Cancer Management and Outcomes
Pancreatic and Hepatic Oncology Research
Publication details
- Journal / source
- Translational Cancer Research
- Volume
- 15
- Issue
- 3
- Pages
- 161–161
- Publication date
- 1 March 2026
- Language
- EN